VOV.VN - A haul of 700 samples of Covivac, a Vietnamese produced COVID-19 vaccine, have been sent to Canada to have its effectiveness evaluated, according to Assoc. Prof. Dr. Vu Dinh Thiem, director of the Center for Clinical Trials under the National Institute of Hygiene and Epidemiology.
VOV.VN - Vietnam is starting phases 2 and 3 of its human clinical trial of the ARCT-154 vaccine against COVID-19 following the encouraging results of the first phase.
VOV.VN - As many as 81 volunteers were given their second jab of the locally-produced Covivac vaccine on September 15 as it entered the second phase of human clinical trials.
VOV.VN - The Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients on August 29 did not approve Nano Covax, the first locally produced COVID-19 vaccine, and requested additional data to ensure the vaccine is completely safe and effective.
VOV.VN - More than 60 volunteers are poised to be given the first jab of the locally-produced COVIVAC vaccine on August 18 following it entering the second phase of clinical trials.
VOV.VN - The National Institute of Hygiene and Epidemiology is set to recruit the first group of volunteers on August 10 for the second phase of clinical trials of the locally-produced COVIVAC vaccine in the northern province of Thai Binh.
VOV.VN - Vietnamese scientists are set to conduct the second phase of a human clinical trial of locally produced COVID-19 vaccine Covivac in August following encouraging results in the first phase.
Vietnam strives to have at least one successful domestically developed COVID-19 vaccine this year, according to deputy health minister Tran Van Thuan.
VOV.VN - Samples of Covivac, a Vietnamese produced coronavirus vaccine, have been sent to Canada for evaluation of its effectiveness, according to Prof. Dr. Dang Duc Anh, director of the National Institute of Hygiene and Epidemiology (NIHE).
VOV.VN - Prime Minister Pham Minh Chinh requested on June 7 that the Ministry of Health, the Ministry of Science and Technology, and other relevant agencies create the best possible conditions to boost the research and production of domestically-made COVID-19 vaccines.